{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:34:03Z","timestamp":1792593243255,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874083"],"award-info":[{"award-number":["81874083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072776"],"award-info":[{"award-number":["82072776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072775"],"award-info":[{"award-number":["82072775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702468"],"award-info":[{"award-number":["81702468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802966"],"award-info":[{"award-number":["81802966"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902540\uff1b81874082"],"award-info":[{"award-number":["81902540\uff1b81874082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472353"],"award-info":[{"award-number":["81472353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The microenvironment of hypoxia is an important factor contributing to the development of glioblastoma (GBM). MicroRNA-588 and its potential target Roundabout-directed receptor 1 (ROBO1) have been reported to promote tumor invasion and proliferation in diseases such as gastric, pancreatic and hepatocellular carcinoma, while their function in GBM and response to hypoxic states remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A microarray was leveraged to identify differentially expressed microRNAs in U251 glioma cells cultured under normoxic and hypoxic conditions. The expression of miR-588 was assessed using quantitative real-time PCR (qRT\u2012PCR). Gain- and loss-of-function studies were used to evaluate the role of miR-588 under hypoxic and normoxic conditions. Cell invasion, migration, proliferation, and vasculogenic mimicry (VM) formation experiments were performed. The relationship between miR-588 and ROBO1 was confirmed using western blot and luciferase reporter assays. Intracranial xenograft tumor mouse models were used to study the function of miR-588 in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of miR-588 was significantly upregulated in hypoxic glioma cells relative to normoxic glioma cells. miR-588 inhibited the invasive, migratory and VM-forming abilities of glioma cells in vitro and in vivo. Mechanistically, roundabout guidance receptor 1 (ROBO1) is a direct, functionally relevant target of miR-588 in glioma. ROBO1 knockdown suppressed the expression of matrix metallopeptidase 2 (MMP2) and matrix metallopeptidase 9 (MMP9), thereby inhibiting the invasive, migratory and VM-forming abilities of glioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MiR-588 regulated the behaviors of hypoxic glioma cells by targeting ROBO1. miR-588 can be used as a prognostic marker for glioma and has potential implications in glioma gene therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11033-022-08063-z","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:33:10Z","timestamp":1669980790000},"page":"1333-1347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNA-588 regulates the invasive, migratory and vasculogenic mimicry-forming abilities of hypoxic glioma cells by targeting ROBO1"],"prefix":"10.1007","volume":"50","author":[{"given":"Rui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongpu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-9330","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"8","key":"8063_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"D Louis","year":"2021","unstructured":"Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D, Hawkins C, Ng H, Pfister S, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"issue":"7","key":"8063_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching H, Knobbe-Thomsen C (2017) Weller MJNrCo: Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol 14(7):434\u2013452","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"8063_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/neuonc\/now258","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell N, Larion M, Giles AJ, Seldomridge AN, Sizdahkhani S, Gilbert MR, Park DM (2017) Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol 19(7):887\u2013896","journal-title":"Neuro Oncol"},{"issue":"24","key":"8063_CR4","doi-asserted-by":"publisher","first-page":"8177","DOI":"10.1158\/1078-0432.CCR-04-1081","volume":"10","author":"SM Evans","year":"2004","unstructured":"Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM et al (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10(24):8177\u20138184","journal-title":"Clin Cancer Res"},{"issue":"14","key":"8063_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1212\/01.wnl.0000345668.03039.90","volume":"72","author":"PL Nghiemphu","year":"2009","unstructured":"Nghiemphu PL, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS et al (2009) Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology 72(14):1217\u20131222","journal-title":"Neurology"},{"key":"8063_CR6","first-page":"Cd008218","volume":"11","author":"M Ameratunga","year":"2018","unstructured":"Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M (2018) Anti-angiogenic therapy for high-grade glioma. Cochrane Database Systematic Rev 11:Cd008218","journal-title":"Cochrane Database Systematic Rev"},{"issue":"Pt 4","key":"8063_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/brain\/awq044","volume":"133","author":"S El Hallani","year":"2010","unstructured":"El Hallani S, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL, Eichmann A et al (2010) A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain 133(Pt 4):973\u2013982","journal-title":"Brain"},{"issue":"2","key":"8063_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-011-0578-5","volume":"105","author":"XM Liu","year":"2011","unstructured":"Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K, Pang JC, Ng HK, Chen ZP (2011) Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol 105(2):173\u2013179","journal-title":"J Neurooncol"},{"key":"8063_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pharmthera.2016.01.006","volume":"159","author":"MJ Hendrix","year":"2016","unstructured":"Hendrix MJ, Seftor EA, Seftor RE, Chao JT, Chien DS, Chu YW (2016) Tumor cell vascular mimicry: Novel targeting opportunity in melanoma. Pharmacol Ther 159:83\u201392","journal-title":"Pharmacol Ther"},{"issue":"3","key":"8063_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics: A comprehensive review. EMBO Mol Med 4(3):143\u2013159","journal-title":"EMBO Mol Med"},{"issue":"2","key":"8063_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41388-019-0996-y","volume":"39","author":"M Qian","year":"2020","unstructured":"Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W, Gao X, Chen Z, Xu J, Zhao R et al (2020) Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-kappaB pathways. Oncogene 39(2):428\u2013442","journal-title":"Oncogene"},{"key":"8063_CR12","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.12659\/MSM.905126","volume":"23","author":"M Yu","year":"2017","unstructured":"Yu M, Zhang X, Li H, Zhang P, Dong W (2017) MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer. Med Sci Monit 23:5690\u20135696","journal-title":"Med Sci Monit"},{"key":"8063_CR13","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.2147\/CMAR.S176954","volume":"10","author":"X Zhou","year":"2018","unstructured":"Zhou X, Xu M, Guo Y, Ye L, Long L, Wang H, Tan P, Xu M (2018) MicroRNA-588 regulates invasion, migration and epithelial-mesenchymal transition via targeting EIF5A2 pathway in gastric cancer. Cancer Manage Res 10:5187\u20135197","journal-title":"Cancer Manage Res"},{"issue":"4","key":"8063_CR14","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3892\/mmr.2016.5643","volume":"14","author":"L Qian","year":"2016","unstructured":"Qian L, Lin L, Du Y, Hao X, Zhao Y, Liu X (2016) MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma. Mol Med Rep 14(4):3021\u20133028","journal-title":"Mol Med Rep"},{"key":"8063_CR15","unstructured":"Zhao N, Lin T, Zhao C, Zhao S, Zhou S, Li Y (2017) MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications. J Cell Biochem"},{"issue":"3","key":"8063_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1261\/rna.5235104","volume":"10","author":"G Meister","year":"2004","unstructured":"Meister G, Landthaler M, Dorsett Y, Tuschl T (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA (New York, NY) 10(3):544\u2013550","journal-title":"RNA (New York, NY)"},{"issue":"3","key":"8063_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203\u2013222","journal-title":"Nat Rev Drug Discov"},{"issue":"46","key":"8063_CR18","doi-asserted-by":"publisher","first-page":"80358","DOI":"10.18632\/oncotarget.18673","volume":"8","author":"X Guo","year":"2017","unstructured":"Guo X, Xu S, Gao X, Wang J, Xue H, Chen Z, Zhang J, Guo X, Qian M, Qiu W et al (2017) Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4\/AKT\/EMT pathway in human glioblastoma cells. Oncotarget 8(46):80358\u201380372","journal-title":"Oncotarget"},{"issue":"29","key":"8063_CR19","doi-asserted-by":"publisher","first-page":"24821","DOI":"10.1074\/jbc.M111.334540","volume":"287","author":"R Francescone","year":"2012","unstructured":"Francescone R, Scully S, Bentley B, Yan W, Taylor SL, Oh D, Moral L, Shao R (2012) Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem 287(29):24821\u201324831","journal-title":"J Biol Chem"},{"key":"8063_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-60327-492-0_14","volume":"472","author":"H Ohgaki","year":"2009","unstructured":"Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol (Clifton, NJ) 472:323\u2013342","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"7","key":"8063_CR21","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2174\/1871527311201070878","volume":"11","author":"MP Mongiardi","year":"2012","unstructured":"Mongiardi MP (2012) Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells. CNS Neurol Disord 11(7):878\u2013883","journal-title":"CNS Neurol Disord"},{"issue":"3","key":"8063_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-009-9827-2","volume":"92","author":"RL Jensen","year":"2009","unstructured":"Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92(3):317\u2013335","journal-title":"J Neurooncol"},{"issue":"26","key":"8063_CR23","doi-asserted-by":"publisher","first-page":"41947","DOI":"10.18632\/oncotarget.16710","volume":"8","author":"Y Song","year":"2017","unstructured":"Song Y, Zheng S, Wang J, Long H, Fang L, Wang G, Li Z, Que T, Liu Y, Li Y et al (2017) Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K\/Akt signaling in glioma. Oncotarget 8(26):41947\u201341962","journal-title":"Oncotarget"},{"key":"8063_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jocn.2015.10.046","volume":"29","author":"X Zhang","year":"2016","unstructured":"Zhang X, Cheng J, Fu L, Li Q (2016) Overexpression of tissue microRNA10b may help predict glioma prognosis. J Clin Neurosci 29:59\u201363","journal-title":"J Clin Neurosci"},{"issue":"19","key":"8063_CR25","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","volume":"68","author":"T Papagiannakopoulos","year":"2008","unstructured":"Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Can Res 68(19):8164\u20138172","journal-title":"Can Res"},{"issue":"7","key":"8063_CR26","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bjc.2015.91","volume":"112","author":"NS Lai","year":"2015","unstructured":"Lai NS, Wu DG, Fang XG, Lin YC, Chen SS, Li ZB, Xu SS (2015) Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br J Cancer 112(7):1241\u20131246","journal-title":"Br J Cancer"},{"issue":"5","key":"8063_CR27","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1007\/s13277-014-3017-3","volume":"36","author":"F Yang","year":"2015","unstructured":"Yang F, Wang W, Zhou C, Xi W, Yuan L, Chen X, Li Y, Yang A, Zhang J, Wang T (2015) MiR-221\/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. Tumour Biol 36(5):3763\u20133773","journal-title":"Tumour Biol"},{"issue":"8","key":"8063_CR28","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592\u2013603","journal-title":"Nat Rev Cancer"},{"key":"8063_CR29","doi-asserted-by":"publisher","first-page":"251231","DOI":"10.1155\/2010\/251231","volume":"2010","author":"R Rahman","year":"2010","unstructured":"Rahman R, Smith S, Rahman C, Grundy R (2010) Antiangiogenic therapy and mechanisms of tumor resistance in progressive glioma. J Oncol 2010:251231","journal-title":"J Oncol"},{"issue":"5433","key":"8063_CR30","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1126\/science.285.5433.1475","volume":"285","author":"M Barinaga","year":"1999","unstructured":"Barinaga M (1999) New type of blood vessel found in tumors. Science (New York, NY) 285(5433):1475","journal-title":"Science (New York, NY)"},{"issue":"3","key":"8063_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe\u2019er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3):739\u2013752","journal-title":"Am J Pathol"},{"issue":"2","key":"8063_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5732\/cjc.012.10292","volume":"33","author":"Y-S Chen","year":"2014","unstructured":"Chen Y-S, Chen Z-P (2014) Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer 33(2):74\u201379","journal-title":"Chin J Cancer"},{"key":"8063_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40364-015-0034-3","volume":"3","author":"JM Mao","year":"2015","unstructured":"Mao JM, Liu J, Guo G, Mao XG, Li CX (2015) Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets. Biomark Res 3:8","journal-title":"Biomark Res"},{"issue":"9","key":"8063_CR34","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1080\/15548627.2017.1336277","volume":"13","author":"HB Wu","year":"2017","unstructured":"Wu HB, Yang S, Weng HY, Chen Q, Zhao XL, Fu WJ, Niu Q, Ping YF, Wang JM, Zhang X et al (2017) Autophagy-induced KDR\/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy 13(9):1528\u20131542","journal-title":"Autophagy"},{"issue":"D1","key":"8063_CR35","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2018","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S (2018) miRBase: from microRNA sequences to function. Nucleic Acids Res 47(D1):D155\u2013D162","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8063_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13059-019-1629-z","volume":"20","author":"W Liu","year":"2019","unstructured":"Liu W, Wang X (2019) Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol 20(1):18","journal-title":"Genome Biol"},{"key":"8063_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:18","journal-title":"Elife"},{"issue":"6","key":"8063_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198508","volume":"13","author":"P Nguemgo Kouam","year":"2018","unstructured":"Nguemgo Kouam P, Rezniczek GA, Kochanneck A, Priesch-Grzeszkowiak B, Hero T, Adamietz IA, Buhler H (2018) Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells. PLoS ONE 13(6):e0198508","journal-title":"PLoS ONE"},{"issue":"11","key":"8063_CR39","doi-asserted-by":"publisher","first-page":"8943","DOI":"10.1007\/s13277-015-3651-4","volume":"36","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Yin L, Jing H, Zhang H (2015) MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1 in glioblastoma. Tumour Biol 36(11):8943\u20138951","journal-title":"Tumour Biol"},{"key":"8063_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12859-016-0917-9","volume":"17","author":"M Deng","year":"2016","unstructured":"Deng M, Bragelmann J, Schultze JL, Perner S (2016) Web-TCGA: an online platform for integrated analysis of molecular cancer data sets. BMC Bioinform 17:72","journal-title":"BMC Bioinform"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08063-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T12:58:40Z","timestamp":1675169920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08063-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["8063"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08063-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that the research has been carried out in accordance with the World Medical Association Declaration of Helskini. All experimental protocols were approved by the Ethics Committee of the Qilu Hospital (Jinan, China) and performed in accordance with the relevant guidelines and regulations. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Shandong University (Jinan, China).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}